<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e> syndrome (LAHPS) is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> characterized by a <z:hpo ids='HP_0001892'>bleeding tendency</z:hpo> due to <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">factor II deficiency</z:e> associated with the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) autoantibodies </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a patient with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and LAHPS in whom successful treatment of central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:mp ids='MP_0001914'>bleeding</z:mp> due to severe <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">factor II deficiency</z:e> was followed by a major thromboembolic complication </plain></SENT>
<SENT sid="2" pm="."><plain>Literature review revealed 2 other patients with LAHPS who developed <z:mp ids='MP_0005048'>thrombosis</z:mp> resulting from the treatment of <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">factor II deficiency</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We suggest that <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">factor II deficiency</z:e> counterbalances the prothrombotic effect of LAC in LAHPS, and correcting this deficiency may promote <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
</text></document>